Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Did Dell (NYSE:DELL) Surge 11.8% and Seagate Gain About 10% in the AI Hardware Rally?

Key HighlightsDell Technologies (NYSE:DELL) rose about 11.8% to roughly USD 373.68 on November 11, 2026, among the strongest large-cap technology gainers of the session.Seagate Technology gained about 10% to roughly USD 551.72, as storage stocks rallied alongside memory makers.The rally followed a strongQuarterly Reportfrom …

Vinay Lochav | 12 November 2026

What Should Investors Expect When Beasley Broadcast (NASDAQ:BBGI) Reports on November 13, 2026 With EPS Estimate -0.45?

The Rationale: Last Reported Quarter and Management Outlook for Beasley Broadcast Group (NASDAQ:BBGI)

Vinay Lochav | 12 November 2026

Why Did Context Therapeutics (NASDAQ:CNTX) Drop CT-95 With USD 34.4 Million Left in the Bank?

On August 5, 2026 the company announced a prioritization that ended internal development of CT-95, a mesothelin-targeting engager, and is winding down its Phase 1 trial. The filing says it does not expect material future costs there, and the third-quarter figures include estimated close-out …

Vinay Lochav | 12 November 2026

Why Did Coherent (NYSE:COHR) Surge 18% and Monolithic Power Jump 13.9% in the AI Chip Rally?

Shares of Coherent (NYSE:COHR) had additional support. Reports that Microsoft was lobbying against a proposed US plan to ban new Chinese-made optical transceivers highlighted the debate over supply, and Coherent is one of the US-based manufacturers that couldFillany gap if such restrictions are introduced. …

Vinay Lochav | 12 November 2026

Why Did Hemab Therapeutics (NASDAQ:COAG) Report a USD 27.3 Million Loss as Its Phase 3 Trial Began?

Hemab develops antibody therapies for blood coagulation disorders. Its lead asset, sutacimig, is a bispecific antibody now in Phase 3 for Glanzmann thrombasthenia. SOLARA is a single-arm study with a 24-week run-in, then 48 weeks of once-weekly subcutaneous dosing, so each participant acts as …

Vinay Lochav | 12 November 2026

What Should Investors Expect When SurgePays, Inc. (NASDAQ:SURG) Reports on November 13, 2026 With EPS Estimate -0.07?

Second quarter 2026 revenue of USD 16.2 million was the sixth consecutive quarter of sequential growth, according to the company. GrossMarginwas about 18.6%, with some segments showing negative margins, and operating income improved by USD 10.3 million from a loss of USD 6.8 million. …

Vinay Lochav | 12 November 2026

Why Did Corning (NYSE:GLW) Rise 7.43% on a Buy Rating Tied to an AI Fiber Shortage?

Key HighlightsCorning (NYSE:GLW) closed up 7.43% on November 11, 2026, after a majorInvestmentbank initiated coverage with a Buy rating and a USD 134 price target.The bank argued that AI data centers are driving a shortage of optical fiber, supported by multi-yearSupplycontracts with hyperscalers and …

Vinay Lochav | 12 November 2026

Why Did Coya Therapeutics (NASDAQ:COYA) Flag Going Concern Doubt With USD 35.8 Million in Cash?

A going concern note means management's projections show cash will not cover operations for more than one year after the financial statements were issued. The company said it does not expect that USD 35.8 million to last that long and will need substantial additional …

Vinay Lochav | 12 November 2026

What Should Investors Expect When Vistagen Therapeutics (NASDAQ:VTGN) Reports on November 13, 2026 With EPS Estimate -0.37?

The Rationale: Last Reported Quarter and Management Outlook for Vistagen Therapeutics, Inc. (NASDAQ:VTGN)

Vinay Lochav | 12 November 2026

Why Did Teradyne (NASDAQ:TER) Jump 8.30% on a Buy Rating and USD 284 Target?

The most notable part of the call was the market share forecast. The bank expects Teradyne's share of system-on-chip testing to rise from roughly 27% toward 34% by 2030. Two forces support that view. First, large chip buyers increasingly insist on dual sourcing to …

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…